Form 8-K - Current report:
SEC Accession No. 0001193125-21-300175
Filing Date
2021-10-15
Accepted
2021-10-15 17:20:18
Documents
13
Period of Report
2021-10-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d199316d8k.htm   iXBRL 8-K 34380
2 EX-99.1 d199316dex991.htm EX-99.1 51438
  Complete submission text file 0001193125-21-300175.txt   215605

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kod-20211013.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kod-20211013_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kod-20211013_pre.xml EX-101.PRE 10940
6 EXTRACTED XBRL INSTANCE DOCUMENT d199316d8k_htm.xml XML 3217
Mailing Address 1200 PAGE MILL RD PALO ALTO CA 94304
Business Address 1200 PAGE MILL RD PALO ALTO CA 94304 650-281-0850
Kodiak Sciences Inc. (Filer) CIK: 0001468748 (see all company filings)

EIN.: 270476525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38682 | Film No.: 211326761
SIC: 2836 Biological Products, (No Diagnostic Substances)